# Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

> **NCT03719768** · PHASE1 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 16 (actual)

## Conditions studied

- Leptomeningeal Metastases
- Leptomeningeal Disease

## Interventions

- **DRUG:** Avelumab
- **RADIATION:** Whole Brain Radiotherapy

## Key facts

- **NCT ID:** NCT03719768
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-10
- **Primary completion:** 2022-07-19
- **Final completion:** 2024-08-21
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03719768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03719768, "Avelumab With Radiotherapy in Patients With Leptomeningeal Disease". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03719768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*